Related Experiment Videos
HLA and DR antigen frequencies in melanoma patients: possible relation to disease prognosis
Tissue Antigens
|October 1, 1985
Abstract:
The frequency of HLA-DR5 was significantly increased in a large group of malignant melanoma patients (33.7% vs 20.5% for controls). The subgroup of patients with poor prognosis showed both a DR5 increase and a relative decrease in DR1. Although none of these differences was significant after correction for the number of antigens tested, similar findings have been made for other malignancies and further studies should be encouraged.
Insights
Human Leukocyte Antigen (HLA)-DR5 was more common in malignant melanoma patients. A poor prognosis subgroup showed increased DR5 and decreased DR1, suggesting further research into HLA and cancer is warranted.
Area of Science:
- Immunogenetics
- Oncology
Background:
- Human Leukocyte Antigen (HLA) genes play a crucial role in immune response.
- Alterations in HLA antigen frequencies have been associated with various cancers.
Purpose of the Study:
- To investigate the association between HLA-DR antigen frequencies and malignant melanoma.
- To explore potential correlations between specific HLA-DR types and patient prognosis.
Main Methods:
- A case-control study comparing HLA-DR antigen frequencies in a large cohort of malignant melanoma patients and healthy controls.
- Analysis of HLA-DR antigen distribution within patient subgroups based on prognosis.
Main Results:
- A significantly higher frequency of HLA-DR5 was observed in malignant melanoma patients compared to controls (33.7% vs 20.5%).
- Patients with a poor prognosis exhibited an increased frequency of HLA-DR5 and a decreased frequency of HLA-DR1.
- These specific differences did not reach statistical significance after adjusting for multiple testing.
Conclusions:
- The findings suggest a potential association between HLA-DR5 and malignant melanoma susceptibility.
- The observed trends in HLA-DR antigen frequencies in poor prognosis patients warrant further investigation.
- Additional research is recommended to elucidate the role of HLA antigens in melanoma development and progression.